By Steve Scherer ( November 5, 2026, 16:28 GMT | Insight) -- Drugmakers secured experimental treatments, expanded biosimilar portfolios and renegotiated royalty obligations, while life-sciences companies acquired technology and resolved patent disputes. Elsewhere, licensing provided access to solar power technology and computing patents, as AI patent owners simplified access to their portfolios and a patent-pool operator pursued new business opportunities.Pharmaceutical deals led licensing activity as AbbVie and Roche signed licensing deals for experimental treatments, Teva expanded its biosimilar partnership with Samsung Bioepis, and United Therapeutics agreed to buy out royalties owed to a Pfizer subsidiary. Other healthcare transactions covered rare diseases, vision loss, wound care and gene synthesis, while Rhythm Pharmaceuticals renegotiated royalties with LG Chem. Beyond life sciences, InterDigital disclosed a new agreement extending its reach among major computer manufacturers, and First Solar licensed patents supporting next-generation solar technology. Sisvel established a unit to pursue IP businesses outside patent pools, while Music IP Holdings opened an online licensing portal for smaller AI and content companies....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.